DRRX- Probably the next upcoming catalyst may be a partnering deal for transdur-sufentanil. But its still trading about 30 million above cash. My guess is that it could drop a bit further.
ECYT and BMTI which are trading below cash may be better plays.
Market Data 
Markets 
AI
